Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France.

NCT06225882 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Patients With PH1 Treated With Lumasiran in France

Interventions

DRUG: Oxaluria evolution.

Sponsor

Hospices Civils de Lyon